Efficient Lung Cancer-Targeted Drug Delivery Via a Nanoparticle/msc System

Xusheng Wang,Haiyan Chen,Xiaowei Zeng,Wenpeng Guo,Yu Jin,Shan Wang,Ruiyun Tian,Yanjiang Han,Ling Guo,Jimin Han,Yaojiong Wu,Lin Mei
DOI: https://doi.org/10.1016/j.apsb.2018.08.006
IF: 14.903
2019-01-01
Acta Pharmaceutica Sinica B
Abstract:Low targeting efficiency limits the applications of nanoparticles in cancer therapy. The fact that mesenchymal stem cells (MSC) trapped in the lung after systemic infusion is a disadvantage for cell therapy purposes. Here, we utilized MSC as lung cancer-targeted drug delivery vehicles by loading nanoparticles (NP) with anti-cancer drug. MSC showed a higher drug intake capacity than fibroblasts. In addition, MSC showed predominant lung trapping in both rabbit and monkey. IR-780 dye, a fluorescent probe used to represent docetaxel (DTX) in NP, delivered via MSC accumulated in the lung. Both in vitro MSC/A549 cell experiments and in vivo MSC/lung cancer experiments validated the intercellular transportation of NP between MSC and cancer cells. In vivo assays showed that the MSC/NP/DTX drug delivery system exerted primary tumor inhibition efficiency similar to that of a NP/DTX drug system. Collectively, the MSC/NP drug delivery system is promising for lung-targeted drug delivery for the treatment of lung cancer and other lung-related diseases.
What problem does this paper attempt to address?